Biologic Approaches for the Treatment of Partial Tears of the Anterior Cruciate Ligament
Este artículo es originalmente publicado en:
First Published January 25, 2017 research-article
Todos los derechos reservados para:
Copyright © 2017 by American Orthopaedic Society for Sports Medicine. Manuscript content on this site is licensed under Creative Commons Licenses
Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0)
Anterior cruciate ligament reconstruction (ACLR) has been established as the gold standard for treatment of complete ruptures of the anterior cruciate ligament (ACL) in active, symptomatic individuals. In contrast, treatment of partial tears of the ACL remains controversial. Biologically augmented ACL-repair techniques are expanding in an attempt to regenerate and improve healing and outcomes of both the native ACL and the reconstructed graft tissue.
To review the biologic treatment options for partial tears of the ACL.
The potential benefits of these biological augmentation approaches for partial ACL tears are improved healing, better proprioception, and a faster return to sport and activities of daily living when compared with standard reconstruction procedures. However, long-term studies with larger cohorts of patients and with technique validation are necessary to assess the real effect of these approaches.